Levetiracetam in pharma franchise in Odisha

Levetiracetam in PCD pharma franchise in Thiruvananthapuram

Levetiracetam in top pharma company in Mumbai

Levetiracetam in pcd pharma supplier in Delhi

Levetiracetam in phama franchise company in India
Levetiracetam in phama distributor in Bangalore

Home/Products /levetiracetam-750mg-tablet

Lapcetam 750 Tablet

Composition : Levetiracetam (750mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹203/-

Lapcetam 750 Tablet is a potent antiepileptic medication formulated with Levetiracetam (750 mg), designed to effectively manage seizures in patients with epilepsy. It helps in controlling partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures associated with juvenile myoclonic epilepsy. Levetiracetam acts on the synaptic vesicle protein 2A, modulating neurotransmitter release and stabilizing brain activity. This mechanism reduces the likelihood and frequency of abnormal electrical activity in the brain, thereby preventing seizures.

The medication can be used as monotherapy for newly diagnosed patients or as an adjunctive treatment for individuals requiring additional seizure control. It is well-suited for adults and children, offering flexibility and reliability in managing epilepsy. With minimal interactions with other drugs, Lapcetam 750 Tablet is considered safe and effective for long-term use.

Adherence to the prescribed dosage schedule can significantly improve seizure management, allowing patients to regain independence and lead a more fulfilling life. This formulation is particularly helpful for individuals needing higher doses to achieve optimal control over their condition.

Read More

About the Product

Lapcetam 750 Tablet is a potent antiepileptic medication formulated with Levetiracetam (750 mg), designed to effectively manage seizures in patients with epilepsy. It helps in controlling partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures associated with juvenile myoclonic epilepsy. Levetiracetam acts on the synaptic vesicle protein 2A, modulating neurotransmitter release and stabilizing brain activity. This mechanism reduces the likelihood and frequency of abnormal electrical activity in the brain, thereby preventing seizures.

The medication can be used as monotherapy for newly diagnosed patients or as an adjunctive treatment for individuals requiring additional seizure control. It is well-suited for adults and children, offering flexibility and reliability in managing epilepsy. With minimal interactions with other drugs, Lapcetam 750 Tablet is considered safe and effective for long-term use.

Adherence to the prescribed dosage schedule can significantly improve seizure management, allowing patients to regain independence and lead a more fulfilling life. This formulation is particularly helpful for individuals needing higher doses to achieve optimal control over their condition.

Common side effects may include fatigue, dizziness, headache, somnolence, and irritability. Rarely, mood changes or allergic reactions may occur.

Lapcetam 750 Tablet is indicated for treating partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures in epilepsy.

This medicine should only be used under the supervision of a healthcare professional. Abrupt discontinuation can lead to withdrawal seizures. Ensure adherence to the prescribed dosage, and promptly report any unusual side effects to your doctor.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation